267 related articles for article (PubMed ID: 8747382)
1. Polyamines as biomarkers of cervical intraepithelial neoplasia.
Nishioka K; Melgarejo AB; Lyon RR; Mitchell MF
J Cell Biochem Suppl; 1995; 23():87-95. PubMed ID: 8747382
[TBL] [Abstract][Full Text] [Related]
2. Phase I dose de-escalation trial of alpha-difluoromethylornithine in patients with grade 3 cervical intraepithelial neoplasia.
Mitchell MF; Tortolero-Luna G; Lee JJ; Hittelman WN; Lotan R; Wharton JT; Hong WK; Nishioka K
Clin Cancer Res; 1998 Feb; 4(2):303-10. PubMed ID: 9516915
[TBL] [Abstract][Full Text] [Related]
3. Polyamines in pancreatic growth.
Fölsch UR; Löser C; Alves F
Digestion; 1990; 46 Suppl 2():345-51. PubMed ID: 2262066
[TBL] [Abstract][Full Text] [Related]
4. Estradiol control of ornithine decarboxylase mRNA, enzyme activity, and polyamine levels in MCF-7 breast cancer cells: therapeutic implications.
Thomas T; Thomas TJ
Breast Cancer Res Treat; 1994 Feb; 29(2):189-201. PubMed ID: 8012036
[TBL] [Abstract][Full Text] [Related]
5. Polyamine content of Pneumocystis carinii and response to the ornithine decarboxylase inhibitor DL-alpha-difluoromethylornithine.
Merali S; Clarkson AB
Antimicrob Agents Chemother; 1996 Apr; 40(4):973-8. PubMed ID: 8849262
[TBL] [Abstract][Full Text] [Related]
6. Individual and combined effects of alpha-difluoromethylornithine and ovariectomy on the growth and polyamine milieu of experimental breast cancer in rats.
Manni A; Badger B; Glikman P; Bartholomew M; Santner S; Demers L
Cancer Res; 1989 Jul; 49(13):3529-34. PubMed ID: 2499419
[TBL] [Abstract][Full Text] [Related]
7. Dose de-escalation chemoprevention trial of alpha-difluoromethylornithine in patients with colon polyps.
Meyskens FL; Emerson SS; Pelot D; Meshkinpour H; Shassetz LR; Einspahr J; Alberts DS; Gerner EW
J Natl Cancer Inst; 1994 Aug; 86(15):1122-30. PubMed ID: 8028034
[TBL] [Abstract][Full Text] [Related]
8. Effect of alpha-difluoromethylornithine on rectal mucosal levels of polyamines in a randomized, double-blinded trial for colon cancer prevention.
Meyskens FL; Gerner EW; Emerson S; Pelot D; Durbin T; Doyle K; Lagerberg W
J Natl Cancer Inst; 1998 Aug; 90(16):1212-8. PubMed ID: 9719082
[TBL] [Abstract][Full Text] [Related]
9. Randomized phase I chemoprevention dose-seeking study of alpha-difluoromethylornithine.
Love RR; Carbone PP; Verma AK; Gilmore D; Carey P; Tutsch KD; Pomplun M; Wilding G
J Natl Cancer Inst; 1993 May; 85(9):732-7. PubMed ID: 8478959
[TBL] [Abstract][Full Text] [Related]
10. A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma.
Saulnier Sholler GL; Gerner EW; Bergendahl G; MacArthur RB; VanderWerff A; Ashikaga T; Bond JP; Ferguson W; Roberts W; Wada RK; Eslin D; Kraveka JM; Kaplan J; Mitchell D; Parikh NS; Neville K; Sender L; Higgins T; Kawakita M; Hiramatsu K; Moriya SS; Bachmann AS
PLoS One; 2015; 10(5):e0127246. PubMed ID: 26018967
[TBL] [Abstract][Full Text] [Related]
11. Alpha-difluoromethylornithine resistance in Leishmania donovani is associated with increased ornithine decarboxylase activity.
Coons T; Hanson S; Bitonti AJ; McCann PP; Ullman B
Mol Biochem Parasitol; 1990 Feb; 39(1):77-89. PubMed ID: 2154691
[TBL] [Abstract][Full Text] [Related]
12. Role of polyamines in the early adaptive response to jejunectomy in the rat: effect of DFMO on the ileal villus:crypt axis.
Bamba T; Vaja S; Murphy GM; Dowling RH
Digestion; 1990; 46 Suppl 2():410-23. PubMed ID: 2124563
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of ornithine decarboxylase does not prevent intestinal smooth muscle hyperplasia in the rat.
Luck MS; Bass P
Am J Physiol; 1994 Dec; 267(6 Pt 1):G1021-7. PubMed ID: 7810648
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic response of the relatively difluoromethylornithine-resistant human lung tumor cell line NCI H157 to the polyamine analogue N1,N8-bis(ethyl)spermidine.
Casero RA; Go B; Theiss HW; Smith J; Baylin SB; Luk GD
Cancer Res; 1987 Aug; 47(15):3964-7. PubMed ID: 3038303
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal tissue polyamine contents of patients with Barrett's esophagus treated with alpha-difluoromethylornithine.
Gerner EW; Garewal HS; Emerson SS; Sampliner RE
Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):325-30. PubMed ID: 8061581
[TBL] [Abstract][Full Text] [Related]
16. Comparison and characterization of growth inhibition in L1210 cells by alpha-difluoromethylornithine, an inhibitor of ornithine decarboxylase, and N1,N8-bis(ethyl)spermidine, an apparent regulator of the enzyme.
Porter CW; Ganis B; Vinson T; Marton LJ; Kramer DL; Bergeron RJ
Cancer Res; 1986 Dec; 46(12 Pt 1):6279-85. PubMed ID: 3096560
[TBL] [Abstract][Full Text] [Related]
17. The additive effect of alpha-difluoromethylornithine (DFMO) and radiation therapy on a rat glioma model.
Tsukahara T; Tamura M; Yamazaki H; Kurihara H; Matsuzaki S
J Cancer Res Clin Oncol; 1992; 118(3):171-5. PubMed ID: 1548280
[TBL] [Abstract][Full Text] [Related]
18. Luminal polyamines stimulate repair of gastric mucosal stress ulcers.
Wang JY; Johnson LR
Am J Physiol; 1990 Oct; 259(4 Pt 1):G584-92. PubMed ID: 1699428
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of acetyl derivatives of polyamines in cultured polyamine-deficient rat hepatoma cells.
Mamont PS; Seiler N; Siat M; Joder-Ohlenbusch AM; Knödgen B
Med Biol; 1981 Dec; 59(5-6):347-53. PubMed ID: 6803078
[TBL] [Abstract][Full Text] [Related]
20. In vivo inhibition of polyamine biosynthesis and growth in tobacco ovary tissues.
Slocum RD; Galston AW
Plant Cell Physiol; 1985; 26(8):1519-26. PubMed ID: 11539696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]